COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 2350: Articles 23491-23500  | Next

Mass molecular testing for COVID19 using NGS-based technology and a highly scalable workflow
Malta, F. d. M., Amgarten, D. E., Val, F. C., Santana, R. A. F., Cervato, M. C., de Azevedo, B. M. C., Basqueira, M. d. S., Alves, C. O. d. S., Nobrega, M. S., Rebello Pinho, J. R.
10.1101/2020.08.10.20172106 — Posted: 2020-08-11
The selection of reference genome and the search for the origin of SARS-CoV-2
Liu, Y., Yan, C.
10.1101/2020.08.10.245290 — Posted: 2020-08-11 Discussion: Onsite
AT-527 is a potent in vitro replication inhibitor of SARS-CoV-2, the virus responsible for the COVID-19 pandemic
Good, S. S., Westover, J., Jung, K. H., La Colla, P., Collu, G., Moussa, A., Canard, B., Sommadossi, J.-P.
10.1101/2020.08.11.242834 — Posted: 2020-08-11
Identification of key genes in SARS-CoV-2 patients on bioinformatics analysis
Gu, H., Yuan, G.
10.1101/2020.08.09.243444 — Posted: 2020-08-11
A Comprehensive Classification of Coronaviruses and Inferred Cross-Host Transmissions
Fu, Y., Pistolozzi, M., Yang, X., Lin, Z.
10.1101/2020.08.11.232520 — Posted: 2020-08-11
Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15
Pillon, M. C., Frazier, M. N., Dillard, L., Williams, J. G., Kocaman, S., Krahn, J. M., Perera, L., Hayne, C. K., Gordon, J., Stewart, Z. D., Sobhany, M., Deterding, L. J., Hsu, A. L., Dandey, V. P., Borgnia, M. J., Stanley, R. E.
10.1101/2020.08.11.244863 — Posted: 2020-08-11
The impact of COVID-19 on the reproductive health of people living in Australia: findings from an online survey
Coombe, J., Kong, F., Bittleston, H., Williams, H., Tomnay, J., Vaisey, A., Malta, S., Goller, J., Temple-Smith, M., Bourchier, L., Lau, A., Hocking, J. S.
10.1101/2020.08.10.20172163 — Posted: 2020-08-11
Coordinated support for local action: A modeling study of strategies to facilitate behavior adoption in urban poor communities of Liberia for sustained COVID-19 suppression
Skrip, L., Fallah, M. P., Bedson, J., Hebert-Dufresne, L., Althouse, B. M.
10.1101/2020.08.11.20172031 — Posted: 2020-08-11
Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis
Walz, L., Cohen, A. J., Rebaza, A. P., Vanchieri, J., Slade, M. D., Dela Cruz, C. S., Sharma, L.
10.1101/2020.08.10.20172189 — Posted: 2020-08-11 Discussion: Onsite
EPIDEMIC ANALYSIS OF COVID-19 IN ALGERIA BY A GENERALIZED SEIR MODEL
LOUNIS, M., AZEVEDO, J. d. S.
10.1101/2020.08.10.20172155 — Posted: 2020-08-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).